Bactericidal/permeability-increasing protein (BPI) compositions

Details Bactericidal/permeability-increasing protein (BPI) compositions Bactericidal/permeability-increasing protein (BPI) compositions

1999-04-26

2000-05-02

Sayala, Chhaya D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 21, 530350, A61K 3816

Patent

active

060572930

ABSTRACT:
Bactericidal/permeability increasing protein (BPI) and biologically active fragments, analogs and variants thereof are solubilized by lipid carriers including phospholipids, liposomes and nonionic detergents and stabilized against particle formation by poloxamer surfactants.

REFERENCES:
patent: 3839314 (1974-10-01), Fekete et al.
patent: 4478829 (1984-10-01), Landaburu et al.
patent: 4719239 (1988-01-01), Muller et al.
patent: 4933179 (1990-06-01), Allison et al.
patent: 4997664 (1991-03-01), Williams
patent: 5030448 (1991-07-01), Hunter
patent: 5037664 (1991-08-01), Shaked et al.
patent: 5039520 (1991-08-01), Hunter
patent: 5041288 (1991-08-01), Hunter
patent: 5071649 (1991-12-01), Hunter
patent: 5089274 (1992-02-01), Marra et al.
patent: 5096885 (1992-03-01), Pearlman et al.
patent: 5118528 (1992-06-01), Fessi et al.
patent: 5118794 (1992-06-01), Grangeorge et al.
patent: 5133908 (1992-07-01), Stainmesse et al.
patent: 5152979 (1992-10-01), Hunter
patent: 5171739 (1992-12-01), Scott
patent: 5182106 (1993-01-01), Mezrow et al.
patent: 5198541 (1993-03-01), Elsbach et al.
patent: 5234683 (1993-08-01), Hunter et al.
patent: 5234908 (1993-08-01), Szabo et al.
patent: 5234912 (1993-08-01), Marra et al.
patent: 5308834 (1994-05-01), Scott et al.
patent: 5334584 (1994-08-01), Scott et al.
patent: 5348942 (1994-09-01), Little, II et al.
patent: 5439807 (1995-08-01), Grinna
patent: 5488034 (1996-01-01), McGregor et al.
patent: 5696090 (1997-12-01), McGregor et al.
patent: 5932544 (1999-08-01), Arinna
FDA, Division of Drug Information Resources, "Inactive Ingredient Guide" including list of "Currently Marketed Injectable Products," (1991).
FDA review and basis for approval of OB-NDA-86-0909 on FLUOSOLl.RTM. (20% Intravascular Perflorochemical Emulsion), The Green Cross Corp. (1989).
Gazzano-Santoro, et al., "High-Affinity Binding of the Bactericidal/Permeability-Increasing Protein and a Recombinant Amino-Terminal Fragment to the Lipid A Region of Lipopolysaccharide," Infection and Immunity, vol. 60, 4754-4761, (Nov., 1992).
Genentech, Inc., "A Tissue Plasminogen Activator," Product Information (1987).
Gray, et al., "Cloning of the cDNA of a Human Neutrophil Bactericidal Protein," The Journal of Biological Chemistry, vol. 264, No. 16, 9505-9509 (Jun. 5, 1989).
The Green Cross Corporation, "Peruflorochemical Blood Substitutes," Technical Info. Series No. 5 & 7 (1978 and 1981).
Henson, et al., "The Surface Coagulation of Proteins During Shaking," J. Colloid & Interface Sci., 32(1):162-165 (Jan. 1970).
ICI Americans, Inc., "ICI Americas Products For Cosmetics and Pharmaceuticals," Chapters 1-4, pp. 1-39 (1977).
ICI Americas, Inc., "The HLB System," Chapters 1-8, pp. 3-20 (1984).
Kaplan and Fraser, "Formation of Fibres from Protein Monolayers," Nature, 171(4352):559-560 (Mar. 28, 1953).
Krantz, et al., "Sugar Alcohols," Bulletin of School of Medicine, U. of MD, 36:48-56 (1951).
Levine, et al., "The Use of Surface Tension Measurements in the Design of Antibody-Based Product Formulations," J. Parenteral Sci.& Tech., 45(3):160-165 (May-Jun. 1991).
MacRitchie, "Proteins at Interfaces," Adv. Protein Chem., 32:283-326 (1978).
Neugebauer, "A Guide to the Properties and Uses of Detergents in Biology and Biochemistry," Calbiochem.RTM. Brand Chemicals, Hoechst Celanese Corp. (1987).
Ooi, et al., "Endotoxin-neutralizing Properties of the 25 kD N-Terminal Fragment and a Newly Isolated 30 kD C-Terminal Fragment of the 55-60 kD Bactericidal/Permeability-increasing Protein of Human Neutrophils," J. Exp. Med., vol. 174, 649-655 (Sep., 1991).
ORTHO Pharmaceutical Corporation, "Orthocolone OKT-3, " Product Information Package Insert (1986).
The U.S. Pharmacopeia USPXXII, pp. 1763, 1857, and NFXVII, pp. 1960-1, 1967-8.
Wang, et al., "Parenteral Formulations of Proteins and Peptides: Stability and Stabilizers," J. Parenteral Sci. Tech., 42 (Supp. 25):S4-526 (1988).
Weiss, et al., "Cellular and Subcellular Localization of the Bactericidal/Permeability-Increasing Protein of Neutrophils," Blood, vol. 69, No. 2, 652-659 (Feb. 1987).
Weiss, et al., "Resistance to Gram-negative Bacteria to Purified Bactericidal Leukocyte Proteins", J. Clin. Invest., 65:619-628 (Mar., 1980).
Wyandotte Chemicals Corporation, "Information on Applications of Pluronics," pp. 1-13 (Mar. 1, 1952).

Affiliated with

Also associated with

Rating

Bactericidal/permeability-increasing protein (BPI) compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bactericidal/permeability-increasing protein (BPI) compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bactericidal/permeability-increasing protein (BPI) compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1593862